Advertisement

Topics

Kite Pharma Highlights Publication From The NCI Demonstrating Responses In Patients With Metastatic Solid Tumors Treated With T Cell Receptor (TCR) Therapy Targeting MAGE A3

20:00 EDT 16 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Kite Pharma Highlights Publication From The NCI Demonstrating Responses In Patients With Metastatic Solid Tumors Treated With T Cell Receptor (TCR) Therapy Targeting MAGE A3

NEXT ARTICLE

More From BioPortfolio on "Kite Pharma Highlights Publication From The NCI Demonstrating Responses In Patients With Metastatic Solid Tumors Treated With T Cell Receptor (TCR) Therapy Targeting MAGE A3"

Advertisement
Quick Search
Advertisement
Advertisement